GlycoMimetics (GLYC) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts GLYC Hot Sheet
Join SI Premium – FREE
GlycoMimetics (NASDAQ: GLYC) reported Q4 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $0 .
For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Imunon (IMNN) Tops Q2 EPS by 39c
- Protara Therapeutics, Inc. (TARA) Misses Q2 EPS by 2c
- Harvard Bioscience (HBIO) Tops Q2 EPS by 24c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
